High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men
- PMID: 20485520
- PMCID: PMC2869329
- DOI: 10.1371/journal.ppat.1000890
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men
Abstract
Elucidating virus-host interactions responsible for HIV-1 transmission is important for advancing HIV-1 prevention strategies. To this end, single genome amplification (SGA) and sequencing of HIV-1 within the context of a model of random virus evolution has made possible for the first time an unambiguous identification of transmitted/founder viruses and a precise estimation of their numbers. Here, we applied this approach to HIV-1 env analyses in a cohort of acutely infected men who have sex with men (MSM) and found that a high proportion (10 of 28; 36%) had been productively infected by more than one virus. In subjects with multivariant transmission, the minimum number of transmitted viruses ranged from 2 to 10 with viral recombination leading to rapid and extensive genetic shuffling among virus lineages. A combined analysis of these results, together with recently published findings based on identical SGA methods in largely heterosexual (HSX) cohorts, revealed a significantly higher frequency of multivariant transmission in MSM than in HSX [19 of 50 subjects (38%) versus 34 of 175 subjects (19%); Fisher's exact p = 0.008]. To further evaluate the SGA strategy for identifying transmitted/founder viruses, we analyzed 239 overlapping 5' and 3' half genome or env-only sequences from plasma viral RNA (vRNA) and blood mononuclear cell DNA in an MSM subject who had a particularly well-documented virus exposure history 3-6 days before symptom onset and 14-17 days before peak plasma viremia (47,600,000 vRNA molecules/ml). All 239 sequences coalesced to a single transmitted/founder virus genome in a time frame consistent with the clinical history, and a molecular clone of this genome encoded replication competent virus in accord with model predictions. Higher multiplicity of HIV-1 infection in MSM compared with HSX is consistent with the demonstrably higher epidemiological risk of virus acquisition in MSM and could indicate a greater challenge for HIV-1 vaccines than previously recognized.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005;5:783–792. - PubMed
-
- Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med. 2003;9:847–852. - PubMed
-
- Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol. 2003;1:25–34. - PubMed
-
- Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209–2220. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AI067854/AI/NIAID NIH HHS/United States
- AI41534/AI/NIAID NIH HHS/United States
- RR24143/RR/NCRR NIH HHS/United States
- R37 AI028433/AI/NIAID NIH HHS/United States
- P30 CA013148/CA/NCI NIH HHS/United States
- AI28433/AI/NIAID NIH HHS/United States
- AI67854/AI/NIAID NIH HHS/United States
- UL1 RR024143/RR/NCRR NIH HHS/United States
- U19 AI067854/AI/NIAID NIH HHS/United States
- CA13148/CA/NCI NIH HHS/United States
- AI27767/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- HHSN266200400088C/PHS HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- R01 AI094604/AI/NIAID NIH HHS/United States
- R01 AI028433/AI/NIAID NIH HHS/United States
- U01 AI041534/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
